跳至主要内容
临床试验/IRCT20231002059591N1
IRCT20231002059591N1尚未招募4 期

Comparing the effectiveness of the combination of atorvastatin and aspirin with atorvastatin alone on the severity of liver fibrosis in cirrhotic patients referred to Ali Bin Abi Taleb Hospital in2023-2025

Zahedan University of Medical Sciences0 个研究点目标入组 81 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
81

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 75 years(—)
性别
All

入选标准

  • Patients with liver cirrhosis who were diagnosed with symptoms
  • Ultrasound based on cirrhosis

排除标准

  • pregnant woman
  • Statin use in the last year
  • affected hcc
  • Myopathy caused by atherostatin treatment
  • child pugh>13
  • Evidence of infection in the last 4 weeks
  • Hepatornal syndrome in clinical and biochemical evidence in the last 14 days
  • High hepatic encephalopathy 2
  • 3 times increase of aminotransferase in 3 months after starting the study
  • Recent use of febrate, varithromycin and others
  • useP450 inhibitor
  • Esophageal varices
  • Patient dissatisfaction

研究者

发起方
Zahedan University of Medical Sciences

相似试验